141 related articles for article (PubMed ID: 11153733)
21. The Role of Beta-Blockers in the Treatment of Hypertension.
Cruickshank JM
Adv Exp Med Biol; 2017; 956():149-166. PubMed ID: 27957711
[TBL] [Abstract][Full Text] [Related]
22. Role of insulin and norepinephrine in the hypertension of obesity.
Maxwell MH; Heber D; Waks AU; Tuck ML
Am J Hypertens; 1994 May; 7(5):402-8. PubMed ID: 8060572
[TBL] [Abstract][Full Text] [Related]
23. Differing roles of body mass and the renin-angiotensin system in mediating the hypertension syndrome.
Weber MA; Smith DH; Neutel JM
Am J Nephrol; 2000; 20(3):169-74. PubMed ID: 10878396
[TBL] [Abstract][Full Text] [Related]
24. Regional sympathetic nervous activity and oxygen consumption in obese normotensive human subjects.
Vaz M; Jennings G; Turner A; Cox H; Lambert G; Esler M
Circulation; 1997 Nov; 96(10):3423-9. PubMed ID: 9396437
[TBL] [Abstract][Full Text] [Related]
25. Baroreflex sensitivity in obesity: relationship with cardiac autonomic nervous system activity.
Skrapari I; Tentolouris N; Perrea D; Bakoyiannis C; Papazafiropoulou A; Katsilambros N
Obesity (Silver Spring); 2007 Jul; 15(7):1685-93. PubMed ID: 17636086
[TBL] [Abstract][Full Text] [Related]
26. Family history of essential hypertension versus obesity as risk factors for hypertension in adolescents.
Simsolo RB; Romo MM; Rabinovich L; Bonanno M; Grunfeld B
Am J Hypertens; 1999 Mar; 12(3):260-3. PubMed ID: 10192227
[TBL] [Abstract][Full Text] [Related]
27. Effect of obesity on endothelium-dependent, nitric oxide-mediated vasodilation in normotensive individuals and patients with essential hypertension.
Higashi Y; Sasaki S; Nakagawa K; Matsuura H; Chayama K; Oshima T
Am J Hypertens; 2001 Oct; 14(10):1038-45. PubMed ID: 11710783
[TBL] [Abstract][Full Text] [Related]
28. Concomitant Obesity and Metabolic Syndrome Add to the Atrial Arrhythmogenic Phenotype in Male Hypertensive Rats.
Hohl M; Lau DH; Müller A; Elliott AD; Linz B; Mahajan R; Hendriks JML; Böhm M; Schotten U; Sanders P; Linz D
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28919580
[TBL] [Abstract][Full Text] [Related]
29. Sex differences in essential hypertension.
Os I; Kjeldsen SE; Nordby G; Eide I; Lande K; Hjermann I; Westheim A
J Intern Med; 1993 Jan; 233(1):13-9. PubMed ID: 8429281
[TBL] [Abstract][Full Text] [Related]
30. Microvascular reactivity in lean, overweight, and obese hypertensive adolescents.
Monostori P; Baráth A; Fazekas I; Hódi E; Máté A; Farkas I; Hracskó Z; Varga IS; Sümegi V; Gellén B; Bereczki C; Túri S
Eur J Pediatr; 2010 Nov; 169(11):1369-74. PubMed ID: 20552222
[TBL] [Abstract][Full Text] [Related]
31. Role of the sympathetic nervous system in blood pressure maintenance in obesity.
Sowers JR; Whitfield LA; Catania RA; Stern N; Tuck ML; Dornfeld L; Maxwell M
J Clin Endocrinol Metab; 1982 Jun; 54(6):1181-6. PubMed ID: 7042733
[TBL] [Abstract][Full Text] [Related]
32. Exercise tolerance in obese vs. lean adolescents: a systematic review and meta-analysis.
Hansen D; Marinus N; Remans M; Courtois I; Cools F; Calsius J; Massa G; Takken T
Obes Rev; 2014 Nov; 15(11):894-904. PubMed ID: 25132188
[TBL] [Abstract][Full Text] [Related]
33. Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers.
Stewart FM; Freeman DJ; Ramsay JE; Greer IA; Caslake M; Ferrell WR
J Clin Endocrinol Metab; 2007 Mar; 92(3):969-75. PubMed ID: 17192290
[TBL] [Abstract][Full Text] [Related]
34. Weight loss facilitates reduction of left ventricular mass in obese hypertensive patients: The Campania Salute Network.
Lønnebakken MT; Mancusi C; Losi MA; Gerdts E; Izzo R; Manzi MV; De Luca N; de Simone G; Trimarco B
Nutr Metab Cardiovasc Dis; 2019 Feb; 29(2):185-190. PubMed ID: 30559043
[TBL] [Abstract][Full Text] [Related]
35. The relationship between body mass index and pulse pressure in older adults with isolated systolic hypertension.
Martins D; Tareen N; Pan D; Norris K
Am J Hypertens; 2002 Jun; 15(6):538-43. PubMed ID: 12074356
[TBL] [Abstract][Full Text] [Related]
36. Antihypertensive effect of alpha- and beta-adrenergic blockade in obese and lean hypertensive subjects.
Wofford MR; Anderson DC; Brown CA; Jones DW; Miller ME; Hall JE
Am J Hypertens; 2001 Jul; 14(7 Pt 1):694-8. PubMed ID: 11465655
[TBL] [Abstract][Full Text] [Related]
37. Borderline hypertension and obesity: two prehypertensive states with elevated cardiac output.
Messerli FH; Ventura HO; Reisin E; Dreslinski GR; Dunn FG; MacPhee AA; Frohlich ED
Circulation; 1982 Jul; 66(1):55-60. PubMed ID: 7083520
[TBL] [Abstract][Full Text] [Related]
38. Adaptation of vasomotor function of human coronary arterioles to the simultaneous presence of obesity and hypertension.
Fulop T; Jebelovszki E; Erdei N; Szerafin T; Forster T; Edes I; Koller A; Bagi Z
Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2348-54. PubMed ID: 17823369
[TBL] [Abstract][Full Text] [Related]
39. [Arterial rigidity and cardiovascular vagosympathetic activity in normotensive and hypertensive obese patients and type 2 diabetics].
Brahimi M; Dabire H; Platon P; Hadj-Brahim F; Attali JR; Valensi P
Arch Mal Coeur Vaiss; 2001 Aug; 94(8):944-6. PubMed ID: 11575237
[TBL] [Abstract][Full Text] [Related]
40. [Sex differences in the correlation between obesity and hypertension with left ventricular mass and hypertrophy].
Kuch B; Muscholl M; Luchner A; Döring A; Riegger GA; Schunkert H; Hense HW
Z Kardiol; 1996 May; 85(5):334-42. PubMed ID: 8711946
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
